top of page

Case Study 1

HealthTech Scaling
(UAE → Switzerland)

Founder of a UAE‑based HealthTech company

(Data‑Driven Diagnostics)

Objectives

  • Raise USD 15–20m Series A with diversified investor base (GCC sovereign‑linked funds, family offices, Swiss institutions).
     

  • Ensure GCC medical‑data compliance and GDPR/HIPAA equivalence for EU/CH onboarding.
     

  • Secure clinical validation via partnerships with Swiss university hospitals.
     

  • Install governance acceptable to sovereign LPs and Swiss VC funds.

Structuring & Solutions

  1. Dual‑jurisdiction raise: UAE SPV for sovereign‑linked commitments; Swiss HoldCo for institutional onboarding.
     

  2. Cross‑border regulatory risk matrix; data residency and consent architecture to de‑risk trials and commercialization.
     

  3. MoUs with two Swiss hospitals for pilot trials; KPIs embedded (sensitivity/specificity, enrollment, endpoints).
     

  4. Independent board representation (UAE + CH); reserved matters and veto mechanics; information rights and quarterly cadence.
     

  5. ILPA‑aligned reporting; bank and custodian packs prepared for Tier‑1 onboarding.

Outcomes

  • USD 15m raised in two tranches (GCC sovereign + Swiss institutional).
     

  • 3× valuation uplift post‑Series A after Swiss clinical validation milestones.
     

  • Compliance validated by GCC and Swiss legal advisors; PSP/bank onboarding seamless.
     

  • Series B readiness with top‑tier Swiss VC funds; extended runway 18+ months.

bottom of page